Posted: 1 September
Closing date: 7 October
The $19.75 million CTCM program is opening its second and final funding round in September, calling for applications from Australian small to medium-sized enterprises (SMEs) developing home-grown medical devices.
The CTCM program can provide between $250,000 and $1.5 million to SMEs to support early clinical development of medical devices with commercial potential. SMEs are defined as having 199 employees or less.
Projects must focus on the development of a medical device for human use, the purpose of which is to diagnose, prevent, monitor, treat or alleviate a disease or injury, or modify or monitor anatomy or physiological functions of the body.
Funding will only be awarded to projects where the device’s capability has already been validated with research and/or preclinical studies.
Eligible applications must include some level of innovation in hardware (proposals relating to pure software as a medical device (SaMD) are ineligible).
To be eligible, applicants are required to provide a co-contribution dependent on the total CTCM funding requested. Additional in-kind or cash contributions above this threshold will be viewed favourably.
Applications for CTCM Round 2 funding will open on Friday 9 September 2022 and close on Friday 7 October 2022 at 16:00 AEDT.
An Information Session was held online AND in-person at QIMR Berghofer in Brisbane on Tuesday 23 August 2022 – Please view recording at the bottom of this page.
You will hear from MTPConnect and CTCM Partners:
For some tips on preparing your application, view the on-demand webinar on our website ‘Show Me The Money: Preparing Successful Commercialisation Funding Applications (18 Nov 2020)’.
Please review the detailed Funding Guidelines below for further information about eligibility and the application process (made online through SmartyGrants). The sample EOI application form below provides an overview of what is required.
For queries, please contact the CTCM team via email at email@example.com.